Evidence map›Paper›PMID 38096133›Full record

ArticleThe Journal of organic chemistry2024

Expedient Synthesis and Characterization of π-Extended Luciferins.

Donald R Caldwell, Katherine M Townsend, Bethany Kolbaba-Kartchner, Tanya Hadjian, Joseph Ivanic, Anna C Love, Beatrice Malvar, Jeremy Mills, Jennifer A Prescher, Martin J Schnermann

Open access · greenAbstract read
In one paragraph

Article in The Journal of organic chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Donald R CaldwellChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-6023-3733
Katherine M TownsendDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Bethany Kolbaba-KartchnerSchool of Molecular Sciences, Arizona State University, Tempe, Arizona 85281, United States.
Tanya HadjianDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Joseph IvanicAdvanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702, United States.ORCID 0000-0003-2104-7169
Anna C LoveDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Beatrice MalvarDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Jeremy MillsSchool of Molecular Sciences, Arizona State University, Tempe, Arizona 85281, United States.ORCID 0000-0003-2017-1846
Jennifer A PrescherDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.ORCID 0000-0002-9250-4702
Martin J SchnermannChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-0503-0116
University of California, Irvine · USArizona State University · USFrederick National Laboratory for Cancer Research · USLeidos (United States) · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI PENDLETON, RICHARD · 2019 to 2025
$3932.6M
Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Synthesis and evaluation of small-molecule imaging agentsZIABC011506 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNERMANN, MARTIN · 2013 to 2025
$12.1M
purchase of an All-in-One Fluorescence MicroscopeR01GM107630 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PRESCHER, JENNIFER · 2013 to 2021
$2.6M
New tools for quantitative non-invasive recording of biochemical signalsR01CA279813 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer Prescher, Nathan Christopher Shaner · 2024 to 2026
$2.0M
NCI NIH HHS 75N91019D00024NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA279813NIGMS NIH HHS R01 GM107630
6 · The paper itself

Abstract

Bioluminescence imaging enables the sensitive tracking of cell populations and the visualization of biological processes in living systems. Bioluminescent luciferase/luciferin pairs with far-red and near-infrared emission benefit from the reduced competitive absorption by blood and tissue while also facilitating multiplexing strategies. Luciferins with extended π-systems, such as AkaLumine and recently reported CouLuc-1 and -3, can be used for bioluminescence imaging in this long wavelength regime. Existing synthetic routes to AkaLumine and similar π-extended compounds require a multistep sequence to install the thiazoline heterocycle. Here we detail the development of a two-step strategy for accessing these molecules via a Horner-Wadsworth-Emmons reaction and cysteine condensation sequence from readily available aldehyde starting materials. We detail an improved synthesis of AkaLumine, as well as the corresponding two-carbon homologues, Tri- and Tetra-AkaLumine. We then extended this approach to prepare coumarin- and naphthalene-derived luciferins. These putative luciferins were tested against a panel of luciferases to identify capable emitters. Of these, an easily prepared naphthalene derivative exhibits photon emission on par with that of the broadly used Akaluc/AkaLumine pair with similar emission maxima. Overall, this chemistry provides efficient access to several bioluminescent probes for a variety of imaging applications.

Indexed as

CoumarinsFirefly LuciferinLuciferasesLuminescent AgentsLuminescent MeasurementsMolecular StructureNaphthalenesCoumarinsFirefly LuciferinLuciferasesLuminescent AgentsNaphthalenes

Identifiers

PMID38096133
PMCPMC11323054
OpenAlexW4389728916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.